You are using an older browser version. Please use a supported version for the best MSN experience.

Reata CEO on positive trial results for drug to treat Friedreich's ataxia

Warren Huff, Reata Pharma CEO, joins CNBC's "Power Lunch" team to discuss his company's positive clinical trial results for a drug to treat the neuromuscular disease Friedreich's ataxia.

Recent Videos

Featured Partners

image beaconimage beaconimage beacon